Search research articles
Contact Us
Filters
Showing results (21-30 of 97) with videos related to
Page
of 10
Sort By:
Urology
|
February 15, 2011
Doppler ultrasound-guided percutaneous nephrolithotomy: a prospective randomized study
Bing-Chang Tzeng, Chung-Jing Wang, Shi-Wei Huang, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 2, 2010
Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies
Robert M Sharkey, Edmund A Rossi, Chien-Hsing Chang, et al.
The Journal of Urology
|
November 16, 2010
Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study
Chung-Jing Wang, Yu-Nan Lin, Shi-Wei Huang, et al.
Biotechnology Progress
|
April 8, 2011
A new mammalian host cell with enhanced survival enables completely serum-free development of high-level protein production cell lines
Diane L Rossi, Edmund A Rossi, David M Goldenberg, et al.
Bioconjugate Chemistry
|
November 3, 2012
Optimization of multivalent bispecific antibodies and immunocytokines with improved in vivo properties
Edmund A Rossi, Chien-Hsing Chang, Thomas M Cardillo, et al.
Plos One
|
September 27, 2014
In-vivo fusion of human cancer and hamster stromal cells permanently transduces and transcribes human DNA
David M Goldenberg, Robert J Rooney, Meiyu Loo, et al.
BMC Cancer
|
April 4, 2013
Targeting both IGF-1R and mTOR synergistically inhibits growth of renal cell carcinoma in vitro
Thomas M Cardillo, Preeti Trisal, Roberto Arrojo, et al.
Blood
|
August 28, 2009
CD20-targeted tetrameric interferon-alpha, a novel and potent immunocytokine for the therapy of B-cell lymphomas
Edmund A Rossi, David M Goldenberg, Thomas M Cardillo, et al.
Plos One
|
May 23, 2013
Interferon-λ1 linked to a stabilized dimer of Fab potently enhances both antitumor and antiviral activities in targeted cells
Donglin Liu, Chien-Hsing Chang, Edmund A Rossi, et al.
Blood
|
April 18, 2009
Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma
Edmund A Rossi, David M Goldenberg, Thomas M Cardillo, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 97) with videos related to
Sort By:
Page
of 10
Urology
|
February 15, 2011
Doppler ultrasound-guided percutaneous nephrolithotomy: a prospective randomized study
Bing-Chang Tzeng, Chung-Jing Wang, Shi-Wei Huang, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 2, 2010
Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies
Robert M Sharkey, Edmund A Rossi, Chien-Hsing Chang, et al.
The Journal of Urology
|
November 16, 2010
Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study
Chung-Jing Wang, Yu-Nan Lin, Shi-Wei Huang, et al.
Biotechnology Progress
|
April 8, 2011
A new mammalian host cell with enhanced survival enables completely serum-free development of high-level protein production cell lines
Diane L Rossi, Edmund A Rossi, David M Goldenberg, et al.
Bioconjugate Chemistry
|
November 3, 2012
Optimization of multivalent bispecific antibodies and immunocytokines with improved in vivo properties
Edmund A Rossi, Chien-Hsing Chang, Thomas M Cardillo, et al.
Plos One
|
September 27, 2014
In-vivo fusion of human cancer and hamster stromal cells permanently transduces and transcribes human DNA
David M Goldenberg, Robert J Rooney, Meiyu Loo, et al.
BMC Cancer
|
April 4, 2013
Targeting both IGF-1R and mTOR synergistically inhibits growth of renal cell carcinoma in vitro
Thomas M Cardillo, Preeti Trisal, Roberto Arrojo, et al.
Blood
|
August 28, 2009
CD20-targeted tetrameric interferon-alpha, a novel and potent immunocytokine for the therapy of B-cell lymphomas
Edmund A Rossi, David M Goldenberg, Thomas M Cardillo, et al.
Plos One
|
May 23, 2013
Interferon-λ1 linked to a stabilized dimer of Fab potently enhances both antitumor and antiviral activities in targeted cells
Donglin Liu, Chien-Hsing Chang, Edmund A Rossi, et al.
Blood
|
April 18, 2009
Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma
Edmund A Rossi, David M Goldenberg, Thomas M Cardillo, et al.
Page
of 10